Dietary fiber delivery system

Details Dietary fiber delivery system Dietary fiber delivery system

2006-01-03

2006-01-03

Prats, Francisco (Department: 1651)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Tablets, lozenges, or pills

C424S488000, C424S499000, C514S023000, C514S054000

Reexamination Certificate

active

06982093

ABSTRACT:
A delivery system and method for delivering soluble dietary fibers in a chewable tablet form which is palatable and demonstrates a high degree of consumer acceptability.

REFERENCES:
patent: 3424842 (1969-01-01), Nurmberg
patent: 3974272 (1976-08-01), Polli et al.
patent: 4681771 (1981-07-01), Adachi et al.
patent: 4283432 (1981-08-01), Mitchell et al.
patent: 4285735 (1981-08-01), Mitchell et al.
patent: 4421852 (1983-12-01), Hoehn et al.
patent: 4680189 (1987-07-01), Schumacher et al.
patent: 4724136 (1988-02-01), Scheibl
patent: 4758515 (1988-07-01), Barwald et al.
patent: 4778676 (1988-10-01), Yang et al.
patent: 4824672 (1989-04-01), Day et al.
patent: 4865850 (1989-09-01), Shell et al.
patent: 4871574 (1989-10-01), Yamazaki et al.
patent: 4877627 (1989-10-01), Leitz et al.
patent: 4882152 (1989-11-01), Yang et al.
patent: 4882160 (1989-11-01), Yang et al.
patent: 5013576 (1991-05-01), Nakazawa et al.
patent: 5051408 (1991-09-01), Cooper
patent: 5085883 (1992-02-01), Garleb et al.
patent: 5169671 (1992-12-01), Harada et al.
patent: 5260279 (1993-11-01), Greenberg
patent: 5292518 (1994-03-01), Kuhrts
patent: 5312626 (1994-05-01), Gergely et al.
patent: 5320848 (1994-06-01), Gever et al.
patent: 5342631 (1994-08-01), Yatka et al.
patent: 5403612 (1995-04-01), Huang
patent: 5422346 (1995-06-01), Mitchell et al.
patent: 5425961 (1995-06-01), Yatka et al.
patent: 5444054 (1995-08-01), Garleb et al.
patent: 5445826 (1995-08-01), Kuhrts
patent: 5447741 (1995-09-01), Goldman
patent: 5476678 (1995-12-01), Walter et al.
patent: 5478732 (1995-12-01), Kunz et al.
patent: 5501858 (1996-03-01), Fuisz
patent: 5550113 (1996-08-01), Mann
patent: 4003140 (1991-08-01), None
patent: 203959 (1991-06-01), None
“OTC's Shelf Busters,”Drug Topics, Jan. 25, 1993, pp. 34-39.
“Maalox, Mylanta, Challenge P&G's Metamucil Laxative,”Advertising Age, Jun. 21, 1993, pp. 3,48.
“Laxative Brand Shares,”Marketing Share Reporter, 1995, p. 173.
“Regularly Increasing,”Supermarket News, Aug. 16, 1993, pp. 27-29.
“Demographics Boon to Laxatives,”Chain Drug Review, Jan. 3, 1994, pp. 32,37.
“Competition Remains Stiff in Laxatives,”Chain Drug Review, Aug. 15, 1994.
“Competition in Laxatives Intensifies,”Chain Drug Review, Jan. 2, 1995.
“Seniors a Key to Strong Laxative Sales,”Drug Topics, Feb. 20, 1995, pp. 63-64.
“Laxative Category Still in Doldrums,”Chain Drug Review, Aug. 14, 1995, p. 12.
“Private Label Dominates Laxatives,”Chain Drug Review, Jan. 1, 1996.
MMR/IRI H&BA Report, Laxative Sales Ending Feb. 25, 1996.
“Productive, Not Popular,”Supermarket Business, Sep., 1996, pp. 113-114, 116,120.
MMR/IRI H&BA Report, Laxative Sales Ending Jun. 30, 1996.
“Laxative Market in Doldrums,”Chain Drug Review, Aug. 12, 1996, p. 48.
“Laxatives Arena in Need of a Spark,”Chain Drug Review, Jan. 6, 1997.
“Laxatives,”Drug Topics, Mar. 3, 1997, p. 92.
MMR/IRI H&BA Report, Laxative Sales Ending Mar. 2, 1997; May, 1997.
MMR/IRI H&BA Report, Laxative Sales Ending 1998.
“Laxative Category Remains in Doldrums,”Chain Drug Review, Aug. 4, 1997, pp. 21, 74.
“Laxative Segment in Doldrums,”Chain Drug Review, Jan. 5, 1998.
“Bolus Obstruction of Gut After Use of Hydrophillic Colloid Laxatives”.Brit. Med. J., 1965; 166-168.
“Distal Esophageal Obstruction Due to a Guar Gum Preparation (Cal-Ban 3000).”Southern Medical Journal1992; vol. 85(6): 642-645.
“The Dark Side of Fiber”Geriatric Nursing, Jan./Feb., 1991, p. 43.
“Agents Affecting Gastrointestinal Water Flux and Motility”Goodman and Gilman's The Pharmacological Basis of Therapeutics, 1990; 8 edition: Chapter 38, p. 914-32; Adverse Effects, p. 918.
“Dietary Fiber,”Modern Nutrition in Health and Disease, 1994; 8 edition: Chapter4, p. 89, 97.
“Bulk-Forming Laxatives and Antacids to Carry New Warnings,”Mayo Clinic Health Letter, Mar. 1994, p. 3.
FDA Public Affairs “P90-39 News Release”,HHS News, Jul. 27, 1990.
“111 Ingredients P90-50 News Release”FDA News Release, Oct. 29, 1990.
“Warning Statements Required for Over-the-Counter Drugs Containing Water Soluble Gums as Active Ingredients,”Federal Register; vol. 55, No. 210, Oct. 30, 1990, p. 45782-85.
“FDA to Ban 111 Diet Product Ingredients,”FDA News Release; P91-17: Aug. 7, 1991.
“FDA Orders Nature's Way Guar Gum Diet Pills Off Market,”FDA News Release; T92-14: Mar. 18, 1992.
FDA “P93-35 Press Release,”FDA News Release, Aug. 26, 1993.
“Warning Statements Required for Over-the-Counter Drugs Containing Water Soluble Gums as Active Ingredients,”Federal Registervol. 58, Aug. 26, 1993, p. 45194-45201.
“Complete Obstruction of Esophagus Following Serutran Ingestion,”JAMA, Jul. 21, 1951; 146(12):1129-1131.
“Esophageal Obstruction Due to Hygroscopic Gum Laxative,”The Lancet, Feb. 16, 1980; 1:364-365.
“Acute Esophageal Obstruction by a Psyllium-Based Bulk Laxative,”Chest, 86(5) Nov., 1984 p. 800.
“Cellulose Fiber Diet Pills—A New Cause of Esophageal Obstruction,”Arch. Otolaryngol. Head Neck Surg. Sep. 1990, 116, p. 1091.
“Esophageal and Small Bowel Obstruction from Guar Gum-Containing ‘Diet Pills’: Analysis of 26 Cases Reported to The Food and Drug Administration,”The Amer. J. of Gastroenterology, 1992: 87(10) 1424-1428.
“Warning: Feeding Animals Hydrophilic Fiber Sources in Dry Diets,”J. Nutr., 1986; 116:47-49.
“Small-Bowel Obstruction Caused by Oat-Bran Bezoar,”NEJM1989; 320(17) 1148-1149.
“Intestinal Obstruction from Cecal Bezoar; A Complication of Fiber-Containing Tube Feeding,”Nutrition; 1990; 6(1) 115-117.
“Small-Bowel Obstruction from Bran Cereal,”JAMA1990; 263(6): 813-814.
“High-Fibre Problem,”The Practioner, Mar. 8, 1990, p. 206.
“Health Effects of Oligosaccharides,”Food Technology, Oct. 1994, p. 61-65.
“Health Benefits and Practical Assets of High-Fiber Diets,”.,AM J Clin Nutr, 1994; 59 (Supplement) pp. 1242s-7s.
“Dietary Fiber and Health”,JAMA, Jul. 28, 1989, vol. 262, No. 4, pp. 542-546.
“Safety and Benefits of Fructooligosaccharides as Food Ingredients,”Food Technology, Jan. 1994, pp. 85-89.
“Influence of Dietary Neosugar on Selected Bacterial Groups of the Human Faecal Microbiota,”Microbial Ecology in Health and Disease, vol. 7, 1994, pp. 91-97.
“Innovate with Raftilose (R),”Orafti Active Food Ingredients, Mar., 1999.
“Technical Properties of Raftiline (R)”,Orafti Active Food Ingredients, Jul., 1998.
“Esophageal Obstruction With a Dietary Fiber Product Designed for Weight Reduction”J Clin Gastroenterol, 1990; 98:p. 805-807.
“Glucomanna Diet Tablets,”The Medical Journal of Australia, Mar. 17, 1984, p. 350.
“Esophageal Obstruction Caused by Cal-Ban”Gastroenterology, 1990; 98; 805.
“Glucomannan and Risk of Esophageal Obstruction,”British Medical Journal, vol. 292, Mar. 1, 1986, p. 591-2.
“On the Presence of Inulin and Oligofructose as Natural Ingredients in the Western Diet,”Critical Reviews in Food Service and Nutrition, 35(6), p. 525-552 (1995).
“Compressed Tablets by Direct Compression,” Shangraw, U. of Maryland School of Pharmacy, Baltimore, Maryland, p. 195-246.
“Oxytetracyline Tablet Formulations: Effect Of Variations in Binder Concentration and Volume on Granule and Tablet Properties,” A.A. Chalmers et al.,J. Pharm. Pharmac., 1975 28, 228-233.
“Physical Aspects of Wet Granulations I: Distribution Kinetics of Water,” J. T. Carstensen et al.,Journal of Pharmaceutical Sciences, vol. 65, No. 7, Jul. 1976, p. 992-997.
“The Evaluation of Chemical Bind

Affiliated with

Also associated with

Rating

Dietary fiber delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dietary fiber delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dietary fiber delivery system will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3546396